A Safety and Efficacy of Homeopathic Medicine Rhus Toxicodendron 30 in the Treatment of Rheumatoid Arthritis

• Status: Unknown status
• Trial end date: 2014-02-01
• Target enrollment: 0
• Participant gender: All

Summary

the purpose of the study is to assess the safety and efficacy of commonly used Homeopathic medicine Rhustoxicodendron in 30 potency in the treatment of Rheumatoid arthritis.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Healthcare Homoeo Charitable Society
• Treatments: Ethanol

Criteria

Inclusion Criteria:

• those who will provide written consent to participate in the study

• patient willing to turn up for 7th day follow up

• patient who are willing and compliance to the study

• those who are between 25 to 60 years .

• patient who are willing and compliance to the study .

• ESR more then 28 mm.

Exclusion Criteria:

• Participating as a subject in any other clinical research study.

• Children below the age of 25years.

• Female subject who are pregnant or planning for pregnancy within 6 month.

• History of seizures

• Breast feeding women's.

• Patient on treatment for life threatening illness like cancer aids etc.

• Patient should not have any congenital abnormality or patient should not have undergone any operative procedure as consequences of RA.